Preprint Open Access
An open letter to Oran and Topol, and the Annals of Internal Medicine
Muge Cevik;
Isaac I Bogoch;
Gail Carson;
Eric D'Ortenzio;
Krutika Kuppali;
Nicola Low;
Sara Loree;
Alasdair Munro;
Lina Moses;
Harish Nair;
Piero Olliaro;
Louise Sigfrid;
Renaud Vatrinet;
on behalf of the CORRE Network (International COVID-19 Rapid Evidence Reviews Group)
An open letter to Oran and Topol, authors of
“Presence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review” Annals of Internal Medicine. 2020 June 3. https://doi.org/10.7326/M20-3012
and Christine Laine (editor-in-chief The Annals of Internal Medicine)
There is a need to better understand the contribution of asymptomatic SARS-CoV-2 infections (those with no symptoms at all throughout the infection) in driving the current pandemic. However, there are caveats that in our opinion are pertinent when interpreting the reported findings of this review, including the lack of a clear definition of asymptomatic infection and selective inclusion of cross-sectional studies. In addition, there is a problematic interpretation of a narrative review containing a dearth of poor-quality evidence resulting in an overestimate of asymptomatic infections, which might misinform policy response.
| Name | Size | |
|---|---|---|
|
Open letter to Oran and Topol and the Annals of Internal Medicine.pdf
md5:d85d2e60bfc56c92d924d0108efab7c7 |
255.2 kB | Download |
| All versions | This version | |
|---|---|---|
| Views | 9,806 | 5,988 |
| Downloads | 3,996 | 2,801 |
| Data volume | 1.0 GB | 714.8 MB |
| Unique views | 8,558 | 5,265 |
| Unique downloads | 3,694 | 2,643 |
- Publication date:
- June 10, 2020
- DOI:
-
- Keyword(s):
- asymptomatic infections SARS-CoV-2 COVID-19 systematic review evidence synthesis
- Communities:
- License (for files):
- Creative Commons Attribution 4.0 International